14-day Premium Trial Subscription Try For FreeTry Free
$37.02
-0.490 (-1.31%)
At Close: May 06, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 COLL stock ended at $37.02. This is 1.31% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $36.88 to a day high of $37.92.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Collegium Pharmaceutical prices

Date Open High Low Close Volume
Jan 19, 2022 $17.79 $18.19 $17.64 $17.97 202 600
Jan 18, 2022 $18.34 $18.40 $17.82 $17.82 103 200
Jan 14, 2022 $17.97 $18.57 $17.97 $18.54 119 200
Jan 13, 2022 $18.85 $18.85 $18.01 $18.14 150 100
Jan 12, 2022 $19.15 $19.21 $18.71 $18.72 135 100
Jan 11, 2022 $19.16 $19.34 $18.76 $19.14 94 700
Jan 10, 2022 $19.23 $19.23 $18.66 $19.05 125 600
Jan 07, 2022 $19.19 $19.44 $19.05 $19.22 164 500
Jan 06, 2022 $18.99 $19.17 $18.64 $19.13 121 400
Jan 05, 2022 $18.89 $19.29 $18.79 $18.86 192 700
Jan 04, 2022 $19.05 $19.18 $18.78 $18.85 150 877
Jan 03, 2022 $18.60 $19.53 $18.60 $19.09 217 679
Dec 31, 2021 $19.29 $19.43 $18.66 $18.68 199 154
Dec 30, 2021 $19.94 $19.98 $19.26 $19.31 203 253
Dec 29, 2021 $19.46 $19.76 $19.31 $19.57 185 778
Dec 28, 2021 $20.01 $20.09 $19.64 $19.69 149 804
Dec 27, 2021 $19.41 $19.95 $19.36 $19.90 194 056
Dec 23, 2021 $19.36 $19.67 $19.27 $19.46 202 343
Dec 22, 2021 $18.78 $19.25 $18.76 $19.22 201 215
Dec 21, 2021 $19.00 $19.25 $18.48 $18.75 212 716
Dec 20, 2021 $18.47 $18.91 $18.02 $18.86 267 145
Dec 17, 2021 $18.43 $18.89 $18.08 $18.65 697 698
Dec 16, 2021 $18.82 $18.99 $18.36 $18.40 267 192
Dec 15, 2021 $18.59 $18.68 $17.92 $18.65 330 252
Dec 14, 2021 $18.16 $18.55 $18.15 $18.48 346 191
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT